Zenotech Laboratories

Zenotech Laboratories Acquisitions (Net)

The Acquisitions (Net) of Zenotech Laboratories (532039.BO) as of Nov 2, 2026 is 191.52 M INR. In the previous year, Acquisitions (Net) was -169.21 M INR — a change of -213.18% (higher).

Acquisitions (Net)

191.52 MINR

YoY

-213.18%

Last updated:

Acquisitions (Net) of Zenotech Laboratories is 2025 191.52 M INR. Acquisitions (Net) of Zenotech Laboratories was 2024 -169.21 M INR. It decreases by -213.18% higher compared to the previous year.

The Zenotech Laboratories Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2018
11.71 M INR
Jan 1, 2019
18.48 M INR
Jan 1, 2020
9.54 M INR
Jan 1, 2021
937,000.00 INR
Jan 1, 2022
986,000.00 INR
Jan 1, 2023
4.07 M INR
Jan 1, 2024
-169.21 M INR
Jan 1, 2025
191.52 M INR
The Zenotech Laboratories Acquisitions (Net) history
YEARAcquisitions (Net)YoY
191.52 MINR-213.18%
-169.21 MINR-4,254.48%
4.07 MINR+313.08%
986,000.00INR+5.23%
937,000.00INR-90.18%
9.54 MINR-48.39%
18.48 MINR+57.86%
11.71 MINR+5,080.53%
226,000.00INR-99.59%
55.04 MINR+1,309.58%
3.91 MINR-16.74%
4.69 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

Acquisitions (Net) of Zenotech Laboratories is 191.52 M INR in 2025.

Acquisitions (Net) of Zenotech Laboratories changed from -169.21 M INR to 191.52 M INR, representing a -213.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Zenotech Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories